Auna (NYSE:AUNA) Announces Earnings Results, Misses Estimates By $0.11 EPS

Auna (NYSE:AUNA) announced its earnings results on Tuesday. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.11), Zacks reports. Auna had a net margin of 1.53% and a return on equity of 16.25%.

Auna Trading Up 2.0%

Shares of NYSE:AUNA traded up $0.11 during midday trading on Tuesday, reaching $5.49. The company had a trading volume of 460,978 shares, compared to its average volume of 348,364. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. Auna has a 1-year low of $4.09 and a 1-year high of $6.85. The firm has a market cap of $406.04 million, a price-to-earnings ratio of 21.10 and a beta of 0.61. The company has a fifty day simple moving average of $5.14 and a two-hundred day simple moving average of $5.11.

Wall Street Analysts Forecast Growth

AUNA has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a research report on Wednesday, June 24th. Wall Street Zen cut shares of Auna from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 5th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $6.97.

Insider Activity

In other Auna news, Director John Wilton sold 17,574 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $4.17, for a total transaction of $73,283.58. Following the sale, the director owned 49,974 shares in the company, valued at approximately $208,391.58. The trade was a 26.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Leon Jesus Zamora acquired 6,420 shares of Auna stock in a transaction on Friday, May 29th. The shares were purchased at an average cost of $4.15 per share, with a total value of $26,643.00. Following the completion of the purchase, the president directly owned 69,130 shares of the company’s stock, valued at approximately $286,889.50. This represents a 10.24% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have acquired 83,454 shares of company stock worth $357,063.

Institutional Investors Weigh In On Auna

A number of large investors have recently made changes to their positions in the company. Virtu Financial LLC lifted its position in shares of Auna by 43.5% in the 4th quarter. Virtu Financial LLC now owns 16,029 shares of the company’s stock valued at $79,000 after acquiring an additional 4,856 shares in the last quarter. XTX Topco Ltd purchased a new position in Auna during the 4th quarter worth approximately $162,000. Occudo Quantitative Strategies LP purchased a new position in Auna during the 4th quarter worth approximately $84,000. Millennium Management LLC grew its position in Auna by 115.2% during the 4th quarter. Millennium Management LLC now owns 26,475 shares of the company’s stock worth $130,000 after purchasing an additional 14,170 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new stake in Auna during the 4th quarter valued at $196,000.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.